Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
06/14/2000 | EP1007563A1 Hm74a receptor |
06/14/2000 | EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e |
06/14/2000 | EP1007554A1 Oil bodies and associated proteins as affinity matrices |
06/14/2000 | EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION |
06/14/2000 | EP1007546A1 Molecular mimetics of meningococcal b epitopes |
06/14/2000 | EP1007537A1 Receptor protein designated 2f1 |
06/14/2000 | EP1007535A1 Methods and compositions for diagnosis and treatment of breast cancer |
06/14/2000 | EP1007534A1 Bh3 interacting domain death agonist |
06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
06/14/2000 | EP1007092A1 A process for inhibiting complement activation via the alternative pathway |
06/14/2000 | EP1007091A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
06/14/2000 | EP1007090A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens |
06/14/2000 | EP1007089A1 Anticoagulant agents useful in treatment of thrombosis |
06/14/2000 | EP1007074A1 Hypothalamus-specific polypeptides |
06/14/2000 | EP1007072A1 Glial cell line-derived neurotrophic factor receptors |
06/14/2000 | EP1007069A1 Novel coding sequences |
06/14/2000 | EP1006797A1 Serpin enzyme complex receptor-mediated gene transfer |
06/14/2000 | EP1006784A1 Glutathione-s-conjugate transport in plants |
06/14/2000 | EP0782585B1 ELIMINATION OF RHEUMATOID FACTOR INTERFERENCE USING ANTI-Fd ANTIBODIES |
06/14/2000 | CN1256712A Plant pest control |
06/14/2000 | CN1256696A Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
06/14/2000 | CN1256312A New human glutathione peroxidase and its code sequence, preparation and use |
06/13/2000 | US6075181 Human antibodies derived from immunized xenomice |
06/13/2000 | US6075136 Polynucleotide sequence coding a polypeptide with enzymatic activity; for treating or preventing cancer and reproductive defects; anticarciongenic agents |
06/13/2000 | US6075128 Materials and methods for isolating IgA immunoglobulins |
06/13/2000 | US6075125 Preparing antibodies against a genetically engineered immunological protein; administering transfected cells to a chicken, activating immune response, recovering antibodies |
06/13/2000 | US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents |
06/13/2000 | US6075119 Particles useful in the prevention and treatment of staphylococcal or streptococcal infection |
06/13/2000 | US6075008 Method for promoting cell proliferation and growth |
06/13/2000 | US6074873 Nucleic acids encoding NL-3 |
06/13/2000 | US6074872 Nucleic acid sequence coding a nervous system polypeptide; for inducing sleep in mammals and the treatment of sleep defects; for screening potential modulators of sleep |
06/13/2000 | US6074867 Degrading carboxymethylcellulose comprising contacting a sample containing carboxymethylcellulose with enzyme with cellulase activity |
06/13/2000 | US6074841 Don-1 gene and polypeptides and uses therefor |
06/13/2000 | US6074839 Transforming growth factor αHI |
06/13/2000 | US6074833 Monoclonal antibody which may be conjugated to an enzymatic agent, a radioactive agent or a cytotoxic agent; for diagnosis and treatment of bone disorders |
06/13/2000 | US6074816 Oligonucleotides which hybridize to genome of non a and non b hepatitis virus; for probes and primers |
06/13/2000 | US6074689 Colonic delivery of protein or peptide compositions |
06/13/2000 | US6074650 Membrane anchor/active compound conjugate, its preparation and its uses |
06/13/2000 | US6074644 Cytotoxic activity |
06/13/2000 | US6074643 Site-directed chemotherapy of metastases |
06/13/2000 | US6074642 Reduce cell lysing ability of biological complement present in blood |
06/13/2000 | US6074641 Administering monoclonal antibody |
06/13/2000 | US6074640 Preadministering antibody before radiation |
06/13/2000 | US6074638 Composition and method for inhibiting plant disease |
06/13/2000 | CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
06/09/2000 | CA2290711A1 Methods for diagnosing a form of ataxia and compounds for use in the method |
06/08/2000 | WO2000033082A2 Methods for quantitation of hla-dr and cd11b |
06/08/2000 | WO2000032821A1 Methods for making recombinant cells |
06/08/2000 | WO2000032795A1 Dna encoding fusion proteins which are specifically cleavable by copper (ii) ions |
06/08/2000 | WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
06/08/2000 | WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
06/08/2000 | WO2000032780A1 Control of flowering |
06/08/2000 | WO2000032778A2 Methods and compositions for inhibiting neoplastic cell growth |
06/08/2000 | WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
06/08/2000 | WO2000032775A1 Pth1r and pth3r receptors |
06/08/2000 | WO2000032773A1 Compositions and methods for increasing bone mineralization |
06/08/2000 | WO2000032771A1 Pth1r and pth3r receptors, methods and uses thereof |
06/08/2000 | WO2000032769A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
06/08/2000 | WO2000032768A1 Polypeptides capable of interacting with the human topoisomerase iii alpha |
06/08/2000 | WO2000032766A1 Human vanilloid receptors and their uses |
06/08/2000 | WO2000032761A1 Ethylene-response-factor1 (erf1) in plants |
06/08/2000 | WO2000032752A1 Psca: prostate stem cell antigen and uses thereof |
06/08/2000 | WO2000032745A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
06/08/2000 | WO2000032635A2 Tumor specific human monoclonal antibodies and methods of use |
06/08/2000 | WO2000032634A1 Humanized antibodies to gamma-interferon |
06/08/2000 | WO2000032633A1 Novel adhesion molecule and methods of use |
06/08/2000 | WO2000032624A2 Uncoupling protein 5 - ucp5 |
06/08/2000 | WO2000032239A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
06/08/2000 | WO2000032231A1 Stimulation of t cells against self antigens using ctla-4 blocking agents |
06/08/2000 | WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization |
06/08/2000 | WO2000018923A3 Slgp protein and nucleic acid molecule and uses therefor |
06/08/2000 | WO2000015659A3 Stomach polypeptide zsig28 |
06/08/2000 | WO2000014200A3 Essential bacterial genes and their use |
06/08/2000 | WO2000012535A3 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
06/08/2000 | WO2000011191A3 Tpl-2/cot kinase and methods of use |
06/08/2000 | WO2000011183A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
06/08/2000 | WO2000004137A9 Human aspartic proteases |
06/08/2000 | WO1999043803A9 Genomic gene encoding hm1.24 antigen protein and promoter thereof |
06/08/2000 | CA2566516A1 Psca: prostate stem cell antigen and uses thereof |
06/08/2000 | CA2503475A1 Promotion or inhibition of angiogenesis and cardiovascularization |
06/08/2000 | CA2353703A1 Tumor specific human monoclonal antibodies and methods of use |
06/08/2000 | CA2353575A1 Methods for making recombinant cells |
06/08/2000 | CA2353304A1 Polypeptides capable of interacting with the human topoisomerase iii alpha |
06/08/2000 | CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
06/08/2000 | CA2353080A1 Control of flowering |
06/08/2000 | CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
06/08/2000 | CA2352532A1 Compositions and methods for increasing bone mineralization |
06/08/2000 | CA2352468A1 Ethylene-response-factor1 (erf1) in plants |
06/08/2000 | CA2352466A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
06/08/2000 | CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth |
06/08/2000 | CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization |
06/08/2000 | CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/07/2000 | EP1006364A1 Immunoassay for detection of mutant P53 polypeptide in biological fluids |
06/07/2000 | EP1006194A2 C-erbB-2 external domain: GP75 |
06/07/2000 | EP1006186A1 Human genes |
06/07/2000 | EP1006182A2 Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs |
06/07/2000 | EP1006178A2 An immortal cell line derived from grouper Epinephelus coioides and its applications |
06/07/2000 | EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
06/07/2000 | EP1005552A1 Member of the hematopoietin receptor superfamily |
06/07/2000 | EP1005550A1 Ubc7-like ubiquitin-conjugating enzyme |